Download or read book Bring Market Prices to Medicare written by Robert F. Coulam and published by A E I Press. This book was released on 2009 with total page 0 pages. Available in PDF, EPUB and Kindle. Book excerpt: Medicare is quickly approaching insolvency, in part because the program pays too much for the services it provides. In Bring Market Prices to Medicare, Robert F. Coulam, Roger Feldman, and Bryan E. Dowd propose a groundbreaking solution: Use market-based arrangements to set prices for Medicare plans. The authors contend that the federal government should pay only the cost of the most economical health plan in each market area. To accomplish this, both traditional fee-for-service (FFS) Medicare and private Medicare Advantage (MA) would submit bids for the government's business; the federal contribution to premiums would be set to equal the lowest bid in each market area. This competitive pricing system would penalize plans that bid too high-their beneficiaries would pay higher premiums-providing an incentive for plans to offer their best prices. Meanwhile, low-bidding plans would be rewarded with increased enrollment. Such an approach would reduce Medicare spending by 8 percent, shoring up the program's finances while empowering consumers to make sensible choices about their health care. Establishing a competitive pricing system for Medicare will have drawbacks as well: Beneficiaries in some markets would have to pay more to stay in the FFS Medicare plan, while others would lose generous supplementary benefits currently offered by private MA plans in areas where these plans are overpaid. Coulam, Feldman, and Dowd contend that the best way to address public and political opposition to this crucial reform is not to downplay its challenges but rather to consider carefully the needs and expectations of beneficiaries and establish a gradual transition that would alleviate most of the disruption beneficiaries might otherwise experience. Bringing market prices to Medicare is not merely a matter of political strategy or tactics; it will require a fundamental shift in Americans' attitudes toward health care, starting with the realization that Medicare's current payment methods cannot be sustained. A competi
Download or read book Making Medicines Affordable written by National Academies of Sciences, Engineering, and Medicine and published by National Academies Press. This book was released on 2018-03-01 with total page 235 pages. Available in PDF, EPUB and Kindle. Book excerpt: Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
Download or read book The Economics of U S Health Care Policy The Role of Market Forces written by Frank W. Musgrave and published by Routledge. This book was released on 2015-02-24 with total page 191 pages. Available in PDF, EPUB and Kindle. Book excerpt: Designed as a primary text for courses in health care economics and policy analysis, this comprehensive work places the issues and economic analysis of the health care industry in the context of market forces driving the industry, including negotiated markets, managed care, and the growing influence of oligopolies. Written in accessible prose, without the aid of technical jargon and mathematical formulations, the content is rich with applicable, understandable economic concepts and analysis, and examples of market failure and government involvement. Some of the major policy issues covered are drug pricing, Medicare and Medicaid reform, the medically uninsured, for-profit hospital monopoly price power, managed care competitive pricing, and new negotiated markets. The relevant economic concepts employed in the text include price elasticity of demand/supply, market structure from competitive to oligopolistic markets, monopoly pricing power, measures of health care inflation and the biases of the CPI, demand and supply factors, inverse relationship of present health care expenditures as a percentage of GDP, measures/concepts of efficiency, and the role of government in a market era.
Download or read book Pharmaceutical R D written by and published by DIANE Publishing. This book was released on 1993 with total page 380 pages. Available in PDF, EPUB and Kindle. Book excerpt: Analyzes the costs, risks, and economic rewards of pharmaceutical R&D and the impact of public policy on both costs and returns. Examines the rapid increase in pharmaceutical R&D that began in the 1980s in the light of trends in science, technology, drug discovery, and health insurance coverage; Government regulation; product liability; market competition; Federal tax policy; and Federal support of prescription drug research. 12 appendices, including a glossary of terms.
Download or read book Medicaid and Medicare Drug Pricing written by Stephen W. Schondelmeyer and published by . This book was released on 2004 with total page 33 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book The Healthcare Imperative written by Institute of Medicine and published by National Academies Press. This book was released on 2011-01-17 with total page 852 pages. Available in PDF, EPUB and Kindle. Book excerpt: The United States has the highest per capita spending on health care of any industrialized nation but continually lags behind other nations in health care outcomes including life expectancy and infant mortality. National health expenditures are projected to exceed $2.5 trillion in 2009. Given healthcare's direct impact on the economy, there is a critical need to control health care spending. According to The Health Imperative: Lowering Costs and Improving Outcomes, the costs of health care have strained the federal budget, and negatively affected state governments, the private sector and individuals. Healthcare expenditures have restricted the ability of state and local governments to fund other priorities and have contributed to slowing growth in wages and jobs in the private sector. Moreover, the number of uninsured has risen from 45.7 million in 2007 to 46.3 million in 2008. The Health Imperative: Lowering Costs and Improving Outcomes identifies a number of factors driving expenditure growth including scientific uncertainty, perverse economic and practice incentives, system fragmentation, lack of patient involvement, and under-investment in population health. Experts discussed key levers for catalyzing transformation of the delivery system. A few included streamlined health insurance regulation, administrative simplification and clarification and quality and consistency in treatment. The book is an excellent guide for policymakers at all levels of government, as well as private sector healthcare workers.
Download or read book Greater Access to Generic Drugs written by Michelle Meadows and published by . This book was released on 2003 with total page 8 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Prescription Drugs written by Charles B. Norton and published by Nova Science Pub Incorporated. This book was released on 2004-01-01 with total page 225 pages. Available in PDF, EPUB and Kindle. Book excerpt: The sky-rocketing prices of many prescription drugs has various groups in society in an uproar. In theory, prescription drug prices are determined by the forces of supply and demand in the market. But this process of price determination is very complex, involving the interaction of powerful and, perhaps, not-so-powerful parties on both sides of the market. The market power of large, research-based pharmaceutical manufacturers is offset by that of the generic drug producers and large payers for prescription drugs: the insurance companies, governments, and various health care providers (such as hospitals and staffed HMOs). At the retail level, too, there are pressures on various types of retailers -- independent and chain drug stores, mass merchandisers that have pharmacies, and mail order pharmacy services -- that have different degrees of influence on prices they pay to their suppliers, while facing substantial pressure from large payer organisations to reduce retail prices. The pricing of prescription drugs is also of concern more broadly to society as a whole. On the one hand is the ideal goal of insuring quality and affordable health care services to all persons. On the other hand is the need to provide adequate professional and financial incentives to all providers of health care services to ensure their near- and long-term supply. This book examines factors in pricing and possible importation of drugs and medicare coverage.
Download or read book The Role of NIH in Drug Development Innovation and Its Impact on Patient Access written by National Academies of Sciences, Engineering, and Medicine and published by National Academies Press. This book was released on 2020-01-27 with total page 103 pages. Available in PDF, EPUB and Kindle. Book excerpt: To explore the role of the National Institutes of Health (NIH) in innovative drug development and its impact on patient access, the Board on Health Care Services and the Board on Health Sciences Policy of the National Academies jointly hosted a public workshop on July 24â€"25, 2019, in Washington, DC. Workshop speakers and participants discussed the ways in which federal investments in biomedical research are translated into innovative therapies and considered approaches to ensure that the public has affordable access to the resulting new drugs. This publication summarizes the presentations and discussions from the workshop.
Download or read book Rare Diseases and Orphan Products written by Institute of Medicine and published by National Academies Press. This book was released on 2011-04-03 with total page 442 pages. Available in PDF, EPUB and Kindle. Book excerpt: Rare diseases collectively affect millions of Americans of all ages, but developing drugs and medical devices to prevent, diagnose, and treat these conditions is challenging. The Institute of Medicine (IOM) recommends implementing an integrated national strategy to promote rare diseases research and product development.
Download or read book The Politics of Medicare written by Theodore R. R. Marmor and published by Routledge. This book was released on 2017-07-05 with total page 267 pages. Available in PDF, EPUB and Kindle. Book excerpt: On July 30, 1965, President Johnson flew to Independence, Missouri to sign the Medicare bill. The new statute included two related insurance programs to finance substantial portions of the hospital and physician expenses incurred by Americans over the age of sixty-five. Public attempts to improve American health standards have typically precipitated bitter debate, even as the issue has shifted from the professional and legal status of physicians to the availability of hospital care and public health programs. In The Politics of Medicare, Marmor helps the reader understand Medicare's origins, and he interprets the history of the program and explores what happened to Medicare politically as it turned from a legislative act in the mid-1960s to a major program of American government in the three decades since. This is a vibrant study of an important piece of legislation that asks and answers several questions: How could the American political system yield a policy that simultaneously appeased anti-governmental biases and used the federal government to provide a major entitlement? How was the American Medical Association legally overcome yet placated enough to participate in the program? And how did the Medicare law emerge so enlarged from earlier proposals that themselves had caused so much controversy?
Download or read book Medicare for All written by Ken Lefkowitz and published by Routledge. This book was released on 2022-02-22 with total page 74 pages. Available in PDF, EPUB and Kindle. Book excerpt: Healthcare continues to be one of the defining political issues in the United States. Though many progressives argue for an overhaul of the current system based on ethical or humanitarian principles, this important book offers an economic rationale for providing healthcare for all. The purpose of Medicare For All: An Economic Rationale is to demonstrate how current runaway healthcare prices can be addressed by implementing the cost-effectiveness of Medicare For All. Written by a former Corporate Director and healthcare consultant, this book illustrates why the current free market model for healthcare is ultimately failing the country by not containing rising healthcare costs, which has a severe economic impact on all Americans, including those covered by employer medical plans. Major factors in that failure such as the lack of transparency, human decision factors, and high administrative costs in the current system are explored. The book demonstrates that implementing Medicare For All, providing comprehensive benefits with no copays, private insurance premiums, deductibles, or other cost-sharing, will not only improve the lives of most Americans, but will be far more cost-effective than the present system. This is an incisive, important contribution to a topic that continues to shape American political discourse and will be of interest to scholars and professionals engaged in this area as well as politicians and the public in general.
Download or read book Report to the Congress Medicare Payment Policy written by Medicare Payment Advisory Commission (U.S.) and published by . This book was released on 1998 with total page 184 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book The Political Life of Medicare written by Jonathan Oberlander and published by University of Chicago Press. This book was released on 2003-06 with total page 275 pages. Available in PDF, EPUB and Kindle. Book excerpt: In recent years, bitter partisan disputes have erupted over Medicare reform. Democrats and Republicans have fiercely contested issues such as prescription drug coverage and how to finance Medicare to absorb the baby boomers. As Jonathan Oberlander demonstrates in The Political Life of Medicare, these developments herald the reopening of a historic debate over Medicare's fundamental purpose and structure. Revealing how Medicare politics and policies have developed since Medicare's enactment in 1965 and what the program's future holds, Oberlander's timely and accessible analysis will interest anyone concerned with American politics and public policy, health care politics, aging, and the welfare state.
Download or read book Medicare Prescription Drug Coverage For Dummies written by Patricia Barry and published by John Wiley & Sons. This book was released on 2008-11-24 with total page 386 pages. Available in PDF, EPUB and Kindle. Book excerpt: Confused about Medicare’s drug coverage? You’re not alone. Medicare Prescription Drug Coverage For Dummies explains Part D in plain English and shows you how to find the best deal among numerous drug-coverage plan options. Whether you’re new to Medicare or already in the program, you’ll navigate the system with more ease and confidence, avoid pitfalls and scams, and have plenty of help choosing the plan that’s right for you. This easy-to-understand, consumer-friendly guide helps you find out whether Part D affects any drug coverage you already have and weigh the consequences of going without coverage. You’ll find ways to compare plans, identify the one that covers your drugs at the least cost, and make sure you sign up at the right time. And you’ll learn how to minimize your expenses, use the “right” pharmacies, and troubleshoot any problems with your coverage. Discover how to: Decide whether you need Part D Understand how Part D works, from costs to coverage Choose and enroll in the best plan for you Get up and running with Part D Handle the coverage gap Lower your drug costs Join and switch plans Comply with long-term-care rules and rights Challenge plan decisions Avoid scams and hard-sell marketing Now, more than ever, you need clear, reliable information that helps you understand Part D and make smart, cost-saving healthcare decisions. You need Medicare Prescription Drug Coverage For Dummies.
Download or read book Competition and the Cost of Medicare s Prescription Drug Program written by Anna Cook and published by . This book was released on 2014-09-03 with total page 48 pages. Available in PDF, EPUB and Kindle. Book excerpt: The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (the Medicare Modernization Act, or MMA) substantially expanded the federal Medicare program by creating the prescription drug benefit known as Part D. In FY 2013, Medicare Part D covered 39 million people. The federal government spent $59 billion net of premiums on Part D in that year; after accounting for certain payments from states under the program, the net federal cost was $50 billion, which represented 10% of net federal spending for Medicare. A combination of broader trends in the prescription drug market and lower-than-expected enrollment in Part D has contributed to much lower spending for the program than projected when the MMA became law in 2003. This report examines the federal budgetary cost and competitive design of Medicare Part D and compares Medicare Part D and Medicaid Fee for Service. Figures and tables. This is a print on demand report.
Download or read book WHO guideline on country pharmaceutical pricing policies written by and published by World Health Organization. This book was released on 2020-09-29 with total page 70 pages. Available in PDF, EPUB and Kindle. Book excerpt: In recent years, high prices of pharmaceutical products have posed challenges in high- and low-income countries alike. In many instances, high prices of pharmaceutical products have led to significant financial hardship for individuals and negatively impacted on healthcare systems' ability to provide population-wide access to essential medicines. Pharmaceutical pricing policies need to be carefully planned, carried out, and regularly checked and revised according to changing conditions. Strong, well-thought-out policies can guide well-informed and balanced decisions to achieve affordable access to essential health products. This guideline replaces the 2015 WHO guideline on country pharmaceutical pricing policies, revised to reflect the growing body of literature since the last evidence review in 2010. This update also recognizes country experiences in managing the prices of pharmaceutical products.
